Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Panasonic acquires autonomous supply chain firm Blue Yonder

By Brian Buntz | September 17, 2021

Panasonic/BlueYonderPanasonic (TYO: 6752) has announced that it has wrapped up its acquisition of Blue Yonder, a supply chain management company established in Scottsdale, Arizona.

Both companies had similar plans for developing autonomous supply chain technology. The partnership will pair Panasonic’s sensing technology with the edge computing and machine learning capabilities of Blue Yonder.

Having acquired a 20% stake in the company in July 2020, Panasonic now owns 80% of Blue Yonder shares.

Blue Yonder’s most recent valuation was $8.5 billion.

Supply chain disruptions have grown more common during the pandemic, forcing many manufacturers including in the pharmaceutical industry to rethink their logistics strategy.

Part of the promise of autonomous supply chains is their resilience.

“Panasonic’s resources and Blue Yonder’s innovation will accelerate the development of the tools customers need to anticipate and prevent disruptions and breathe autonomy into their supply chains,” said Simon Ellis, program vice president at IDC, in a statement.

Following the acquisition, Panasonic will preserve the Blue Yonder brand and retain the company’s leadership team.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

Bristol Myers Squibb to build new plant in Houston 
Codis Catalent Nottingham UK facility
Codis completes acquisition of Catalent manufacturing plant
Ratio Therapeutics Logo
Ratio Therapeutics raises $70M to expand manufacturing infrastructure
Resilience Lilly_
Resilience, Lilly invest $750M in pharma, KwikPen manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE